Perfusion Imaging and CT -Understanding Relative Efficacy

Stopped early · Not applicable

Conditions studied: Coronary Artery Disease

In brief

To determine the relative efficacy of Cardiac Computed Tomography Angiography (CCTA) and Single Positron Emission Computed Tomography (SPECT) in patients with an intermediate risk of CAD.

Key facts

Study ID

NCT00486447

Run by

GE Healthcare

People needed

249

Starts

2007-06-01

Expected to finish

2009-12-01

Last updated by the study team

2017-08-23

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients with an intermediate probability risk for coronary artery disease.
• Subject has symptoms of suspected ischemic heart disease.
• Subject is at intermediate risk for coronary artery disease

You may not qualify if…

• The subject has undergone a prior CCTA within 6 months prior to entering the study.
• The subject has a documented history of CAD by CATH, myocardial infarction (MI), metal stent placement in any of the coronary vessels, or a previous coronary artery bypass graft (CABG) procedure
• The subject has hemodynamic or active clinical instability:
• Acute chest pain (sudden onset);
• Cardiac shock;
• Unstable blood pressure (BP);
• Severe congestive heart failure or acute pulmonary edema.

Where it is running

• GE Healthcare — Waukesha, Wisconsin, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.